Home › Funds › ShankerValleau Wealth Advisors, Inc. › ABT

ShankerValleau Wealth Advisors, Inc. position in ABT

ABBOTT LABORATORIES · Health Care

ShankerValleau Wealth Advisors, Inc. reported holding 4,624 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$457K, representing 0.12% of its reported portfolio and ranking #27 among its reported holdings. ShankerValleau Wealth Advisors, Inc. first reported this position in Q3 2026.

Latest position (Q3 2026)4.62K sh
Reported value held$456.99K
Portfolio Weight0.12%
First reportedQ3 2026
Last changeNew
Updated2026-10-17

Last updated: 2026-10-17 · Source: SEC EDGAR Form 13F-HR

How ShankerValleau Wealth Advisors, Inc.'s ABT position evolved

ShankerValleau Wealth Advisors, Inc. first disclosed a stake in ABT in Q3 2026 at 4,624 shares (US$457K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 4.62K $456.99K New

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has ShankerValleau Wealth Advisors, Inc. held ABT?

ShankerValleau Wealth Advisors, Inc. has disclosed ABT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is ShankerValleau Wealth Advisors, Inc.'s current position in ABT?

As of Q3 2026, ShankerValleau Wealth Advisors, Inc. holds 4.62K shares of ABT (ABBOTT LABORATORIES), valued at $456.99K, representing 0.12% of its reported portfolio and ranking #27.

Has ShankerValleau Wealth Advisors, Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), ShankerValleau Wealth Advisors, Inc. newly opened its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.